COVID-19: Covaxin phase-3 trial underway in Jaipur Hospital

As the COVID-19 situation continues to be fragile and the threat is still far from over, the Phase-III clinical trial of Covaxin is underway at Maharaja Agarsen Hospital in Rajasthan's Jaipur. The hospital is expected to administer the vaccine to at least 1,000 volunteers which can be later increased to 2,000.

Jaipur: The Phase-III clinical trial of COVID-19 vaccine -- Covaxin being developed by Bharat Biotech is underway at Maharaja Agarsen Hospital in Rajasthan's Jaipur district.

As per the Hospital record, as many as 77 people have been administered the vaccine till now.

Speaking to ETV Bharat, Dr Manish Kumar Jain, who is overviewing the trial, said that volunteers are being administered the vaccine and it is totally safe.

"Volunteers are given the second dose 28 days after the first dose. During this phase, their health is closely monitored and as of now no side effects have not been found," he said.

He further said that the hospital is expected to administer the vaccine to at least 1,000 volunteers which can be later increased to 2,000.

It is pertinent to mention here that Covaxin is being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).